A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer.

Aging (Albany NY) · 2019 · PMC6756873 · PMID 31518336

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

of borderline significancep = 0.052so close (0.05 < p ≤ 0.1)

Survival analysis comparing overall survival between non-diabetic and diabetic patients (p = 0.89) showed no evidence of survival difference between groups and survival differences between antihyperglycemic medication user groups were of borderline significance (p = 0.052).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.